PatientGroups.co
Identify, score, and monitor patient advocacy groups worldwide for pharma partnerships.
Matt Powell · Founder
Pharma intelligence I design, build, and run.
I ship the tools I wished existed in brand, medical, and regulatory roles — patient advocacy mapping, unmet-need research, FDA/EMA monitoring, and PMCPA-ready packs.
Creator tools and France-market advisory sit alongside, clearly labelled, so the picture is complete without diluting the core work.
- 5life-sciences products live
- FDA / EMAmonitored continuously
- PMCPAsubmission-ready packs
- EU / UKVPS via Coolify & Tailscale
Product stack
Grouped by workflow, not by company. Pharma is the core; labs and advisory are labelled so they do not pretend to be the same pitch.
Core focus
Pharma & Life Sciences
Brand, medical, regulatory, and patient-engagement workflows — the work this site is for.
IndicationIQ
Named patient unmet needs and HCP signals from public conversation — every finding backed by a quote.
PromoPack
Turn promotional materials into submission-ready PMCPA reference packs with claim-to-evidence trails.
RegulatoryAlerts
Continuous monitoring of FDA, EMA, and other agencies with therapeutic filtering and executive summaries.
PatientGroups.ai
Free AI-powered directory matching patients and caregivers to verified support communities.
Secondary
Creator Tools & Labs
Not life-sciences products. Tools I built for publishing and branding, listed so the picture is complete.
PostBroadcaster
Plan, create, schedule, and publish social content across networks in one place.
HiddenLogo
AI that weaves a logo into optical-illusion images and branded visuals.
Elliogen
Advisory
When the answer is judgement — France market entry, commercial navigation, technical build decisions — not a login.
Elliogen
Independent strategic advice for market entry and commercial navigation in France.
How this is run
Enterprise buyers ask how a solo founder can be a serious vendor. Fair. The answer is architecture, isolation, and direct access — not a hiring plan.
Reliability without the theatre
Each product is its own deploy. A bad migration on one app does not take the others with it. Backups are practised, not just configured. Live software, not a pitch deck with a roadmap.
EU / UK hosted, privately operated
Production runs on VPS nodes I operate. Coolify ships from git; Tailscale keeps admin planes off the public internet. I do not put identifiable health data in tools that do not need it.
Speed of one person
I design, build, host, and sell it. No waiting on an engineering org to turn a brief into a tool — and no account manager translating you to the person who actually ships.
You talk to the person who ships it
Direct access, by design. When a product is not the answer — France market entry, commercial navigation, a build decision — that is advisory through Elliogen.
Further reading: Building regulated pharma SaaS as a solo founder — the stack and the trade-offs
About
I worked in pharma sales and commercial roles before moving into software — I now build the tools I wished existed back then.
I design, build, and run all of it myself: product, infrastructure, and go-to-market. Patient-advocacy platforms sit in Phormulate Ltd. IndicationIQ, RegulatoryAlerts, PromoPack, the creator tools, and independent advisory sit under Matt Powell T/A Elliogen, with IndicationIQ likely spinning out as its own company as it grows.
If you are a brand team, regulatory function, or agency wrestling with a problem like these, I also take advisory work through Elliogen, including France market entry.